Cross-recognition of human alloantigen by cytomegalovirus glycoprotein-specific CD4+ cytotoxic T lymphocytes: Implications for graft-versus-host disease

Blood

Volumn 105, Issue 3, 2005, Pages 1362-1364

  Elkington, Rebecca ^a   Khanna, Rajiv ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ASPARTYLTYROSYLSERYLASPARAGINYLTHREONYLHISTIDYLSERYLTHREONYLARGINYLTYROSYLVALINE; EPITOPE; GLYCOPROTEIN B; HLA DR4 ANTIGEN; HLA DR7 ANTIGEN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALLELE; ALLOIMMUNITY; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL SPECIFICITY; CLONAL VARIATION; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; HUMAN CYTOMEGALOVIRUS; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS CARRIER;

EID: 12844278562     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2602     Document Type: Article

References (21)

1. Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes. 2003;10:60-65.
2. Meijer E, Boland GJ, Verdonck LF. Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants. Clin Microbiol Rev. 2003;16:647-657.
3. Inkinen K, Soots A, Krogerus L, Bruggeman C, Ahonen J, Lautenschlager I.Cytomegalovirus increases collagen synthesis in chronic rejection in the rat. Nephrol Dial Transplant. 2002;17:772-779.
4. Martelius T, Krogerus L, Hockerstedt K, Bruggeman C, Lautenschlager I. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Hepatology. 1998;27:996-1002.
5. Koskinen PK, Krogerus LA, Nieminen MS, Mattila SP, Hayry PJ, Lautenschlager IT. Cytomegalovirus infection-associated generalized immune activation in heart allograft recipients: a study of cellular events in peripheral blood and endomyocardial biopsy specimens. Transpl Int. 1994;7:163-171.
6. You XM, Steinmuller C, Wagner TO, Bruggeman CA, Haverich A, Steinhoff G. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens. J Heart Lung Transplant. 1996;15:1108-1119.
7. Kraat YJ, Christiaans MH, Nieman FH, van den Berg-Loonen PM, van Hooff JP, Bruggeman CA. Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy. Transpl Int. 1994;7:362-367.
8. Morris DJ, Martin S, Dyer PA, Hunt L, Mallick NP, Johnson RW. HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients. J Med Virol. 1993;41:324-327.
9. Blancho G, Josien R, Douillard D, Bignon JD, Cesbron A, Soulillou JP. The influence of HLA A-B-DR matching on cytomegalovirus disease after renal transplantation. Evidence that HLA-DR7-matched recipients are more susceptible to cytomegalovirus disease. Transplantation. 1992; 54:871-874.
10. Valerio RM, Benstead M, Bray AM, Campbell RA, Maeji NJ. Synthesis of peptide analogues using the multipin peptide synthesis method. Anal Biochem. 1991;197:168-177.
11. Burrows SR, Rodda SJ, Suhrbier A, Geysen HM, Moss DJ. The specificity of recognition of a cytotoxic T lymphocyte epitope. Eur J Immunol. 1992;22:191-195.
12. Elkington R, Walker S, Crough T, et al. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol. 2003;77:5226-5240.
13. Elkington R, Shoukry NH, Walker S, et al Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. Eur J Immunol. 2004;34:3216-3226.
14. Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med. 1995;182:1703-1715.
15. Merkenschlager M, Beverley PC. Evidence for differential expression of CD45 isoforms by precursors for memory-dependent and independent cytotoxic responses: human CD8 memory CTLp selectively express CD45RO (UCHL1). Int Immunol. 1989;1:450-459.
16. Burrows SR, Gardner J, Khanna R, Steward T, Moss DJ, Rodda S, Suhrbier A. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J Gen Virol. 1994;75:2489-2493.
17. Lombardi G, Sidhu S, Batchelor JR, Lechler RI. Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides [published correction appears in Proc Natl Acad Sci U S A. 1989; 86:10074]. Proc Natl Acad Sci U S A. 1989;86:4190-4194.
18. Khanna R, Burrows SR. Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases. Annu Rev Microbiol. 2000;54:19-48.
19. Ashwell JD, Chen C, Schwartz RH. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J Immunol. 1986;136:389-395.
20. Burrows SR, Khanna R, Burrows JM, Moss DJ. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med. 1994;179:1155-1161.
21. Appleton AL, Sviland L. Pathogenesis of GVHD: role of herpes viruses. Bone Marrow Transplant. 1993;11:349-355.